Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 72

Работа: Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

  1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Gregory A. Roth, George A. Mensah, Catherine O. Johnson +71

    Обзорная статьяCardiovascular Health and Risk FactorsJournal of the American College of Cardiology2020Цитирований: 8
    ABI

  2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

    François Mach, Colin Baigent, Alberico L. Catapano +87

    Статья2019Цитирований: 7
    ABI

  3. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L.J. Visseren, François Mach, Yvo M. Smulders +97

    Статья2021Цитирований: 7
    ABI

  4. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries +26

    Статья2013Цитирований: 6
    ABI

  5. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

    Colin Baigent, Anthony Keech, Patricia M. Kearney +8

    Обзорная статья2005Цитирований: 6
    ABI

  6. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller +9

    Статья2018Цитирований: 5
    ABI

  7. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

    William T. Friedewald, Robert I. Levy, Donald S. Fredrickson

    Статья1972Цитирований: 5
    ABI

  8. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A. Ference, Henry N. Ginsberg, Ian Graham +23

    Обзорная статья2017Цитирований: 4
    ABI

  9. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

    Albert Wiegman, Samuel S. Gidding, Gerald F. Watts +29

    Обзорная статья2015Цитирований: 4
    ABI

  10. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    Florian Kronenberg, Samia Mora, Erik S.G. Stroes +19

    Статья2022Цитирований: 3
    ABI

  11. Nonadherence to statins: individualized intervention strategies outside the pill box

    Peter Lansberg, André Lee, Zhen-Vin Lee +2

    Обзорная статья2018Цитирований: 3
    ABI

  12. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

    Christopher P. Cannon, Michael A. Blazing, Robert P. Giugliano +18

    Статья2015Цитирований: 2
    ABI

  13. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    M. Cuchel, Éric Bruckert, H. N. Ginsberg +41

    Статья2014Цитирований: 2
    ABI

  14. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini +37

    Обзорная статья2015Цитирований: 2
    ABI

  15. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

    Anne Langsted, Pia R. Kamstrup, Marianne Benn +2

    Статья2016Цитирований: 2
    ABI

  16. The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification

    Joana Rita Chora, Michael A. Iacocca, Lukáš Tichý +25

    Статья2021Цитирований: 2
    ABI

  17. Recommendations for reporting results of diagnostic genomic testing

    Zandra C. Deans, Joo Wook Ahn, Isabel M. Carreira +7

    Статья2022Цитирований: 2
    ABI

  18. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease

    Berit Storgaard Hedegaard, Christian Sørensen Bork, Morten Kaltoft +5

    Статья2022Цитирований: 2
    ABI

  19. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    Marina Cuchel, Frederick J. Raal, Robert A. Hegele +20

    Статья2023Цитирований: 2
    ABI

  20. High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics

    Berit Storgaard Hedegaard, Børge G. Nordestgaard, Helle Kanstrup +15

    Статья2023Цитирований: 2
    ABI

  21. Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS)

    Jan Kafol, Beatriz Miranda, Rok Sikonja +11

    Статья2025Цитирований: 2
    ABI

  22. Без названия

    ДругоеЦитирований: 1
    ABI

  23. Без названия

    ДругоеЦитирований: 1
    ABI

  24. Без названия

    ДругоеЦитирований: 1
    ABI

  25. Без названия

    ДругоеЦитирований: 1
    ABI